Animal Health Biotechnology Market Report By Regional Analysis, Key Players, Share, Size And Forecast 2024

| April 12, 2017

article image
Biotechnology utilized in animal healthcare dates back to 19th century when the first vaccines were prepared for its use in animals. Considerable progress in the animal health biotechnology took place recently when biotechnology applications were utilized in both detecting and treating various infectious and parasitic diseases of animals.

Spotlight

Matrix Medical South Africa

Medical company that started off with a vision to add value to people's lives and give hope to those who feel that life has given them a raw deal. We deal in Surgicals for hospitals, doctor's and dentists. We are the sole provider of Novearus in South Africa which is a revolutionary infection control product, bringing new dimensions to our medical industry. Also sole supplier of Ami Italia in South Africa, which is AED's for public safety and professional use. Our product development grows consistantly as we find products that we as a company believe can add value to our medical industry, ambulances and hospitals. We are based nationwide.

OTHER ARTICLES

Cell Out? Lysate-Based Expression an Option for Personalized Meds

Article | February 18, 2020

Cell-free expression (CFE) is the practice of making a protein without using a living cell. In contrast with cell line-based methods, production is achieved using a fluid containing biological components extracted from a cell, i.e., a lysate. CFE offers potential advantages for biopharma according to Philip Probert, PhD, a senior scientist at the Centre for Process Innovation in the U.K.

Read More

Learning How FoxA2 Helps Turn Stem Cells into Organs

Article | February 18, 2020

Scientists at the Perelman School of Medicine at the University of Pennsylvania discovered early on in each cell, FoxA2 simultaneously binds to both the chromosomal proteins and the DNA, opening the flood gates for gene activation. The discovery, “Gene network transitions in embryos depend upon interactions between a pioneer transcription factor and core histones,” published in Nature Genetics, helps untangle mysteries of how embryonic stem cells develop into organs, according to the researchers. “Gene network transitions in embryos and other fate-changing contexts involve combinations of transcription factors. A subset of fate-changing transcription factors act as pioneers; they scan and target nucleosomal DNA and initiate cooperative events that can open the local chromatin. However, a gap has remained in understanding how molecular interactions with the nucleosome contribute to the chromatin-opening phenomenon,” write the investigators.

Read More
MEDICAL

Better Purification and Recovery in Bioprocessing

Article | February 18, 2020

In the downstream portion of any bioprocess, one must pick through the dross before one can seize the gold the biotherapeutic that the bioprocess was always meant to generate. Unfortunately, the dross is both voluminous and various. And the biotherapeutic gold, unlike real gold, is corruptible. That is, it can suffer structural damage and activity loss. When discarding the dross and collecting the gold, bioprocessors must be efficient and gentle. They must, to the extent possible, eliminate contaminants and organic debris while ensuring that biotherapeutics avoid aggregation-inducing stresses and retain their integrity during purification and recovery. Anything less compromises purity and reduces yield. To purify and recover biotherapeutics efficiently and gently, bioprocessors must avail themselves of the most appropriate tools and techniques. Here, we talk with several experts about which tools and techniques can help bioprocessors overcome persistent challenges. Some of these experts also touch on new approaches that can help bioprocessors address emerging challenges.

Read More

Ruminating on Bioprocessing 4.0

Article | February 18, 2020

The Bioprocessing 4.0 concept seeks to apply automation and technology to the digital transformation of biologics manufacturing. As the paradigm moves forward, it faces barriers to its adoption, according to Eric Langer, president of BioPlan Associates. “Perhaps the greatest challenges involve unsecured links and adapting the applications to areas where automation is critically needed today,” says Langer. “Unresolved security issues could seriously affect a company’s data in a regulated environment, so they will need to have iron-clad anti-hacking protection in place. Unfortunately, cyber security is not yet a top focus for the industry.”

Read More

Spotlight

Matrix Medical South Africa

Medical company that started off with a vision to add value to people's lives and give hope to those who feel that life has given them a raw deal. We deal in Surgicals for hospitals, doctor's and dentists. We are the sole provider of Novearus in South Africa which is a revolutionary infection control product, bringing new dimensions to our medical industry. Also sole supplier of Ami Italia in South Africa, which is AED's for public safety and professional use. Our product development grows consistantly as we find products that we as a company believe can add value to our medical industry, ambulances and hospitals. We are based nationwide.

Events